Your browser doesn't support javascript.
loading
A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain.
Browne, M J; Carey, J E; Chapman, C G; Tyrrell, A W; Entwisle, C; Lawrence, G M; Reavy, B; Dodd, I; Esmail, A; Robinson, J H.
Affiliation
  • Browne MJ; Beecham Pharmaceuticals Research Division, Biosciences Research Centre, Epsom, Surrey, United Kingdom.
J Biol Chem ; 263(4): 1599-602, 1988 Feb 05.
Article in En | MEDLINE | ID: mdl-2828346
ABSTRACT
The complete cDNA for human tissue-type plasminogen activator (t-PA) was cloned and sequenced. A mutant was constructed by using in vitro site-specific mutagenesis to delete the region encoding the growth factor domain (amino acids 51-87 inclusive). Normal and mutant t-PA species were produced using two mammalian expression systems (in human HeLa cells and mouse C127 cells). The clearance of mutant and normal t-PA from plasma was examined in vivo using a guinea pig model. Mutant t-PA derived from HeLa or C127 cells was cleared much more slowly than the cognate normal t-PA. The potential role of the growth factor domain in the recognition of t-PA by the hepatic clearance mechanism is discussed.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Proteins / Deoxyribonucleases, Type II Site-Specific / Tissue Plasminogen Activator Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Biol Chem Year: 1988 Type: Article Affiliation country: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Proteins / Deoxyribonucleases, Type II Site-Specific / Tissue Plasminogen Activator Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Biol Chem Year: 1988 Type: Article Affiliation country: United kingdom